Skip to main content
Top
Published in: PharmacoEconomics 2/2007

01-02-2007 | Original Research Article

Conjoint Analysis of French and German Parents’ Willingness to Pay for Meningococcal Vaccine

Authors: Dr David Bishai, Roger Brice, Isabelle Girod, Aneta Saleh, Jenifer Ehreth

Published in: PharmacoEconomics | Issue 2/2007

Login to get access

Abstract

Objective:

To estimate the willingness of parents in France and Germany to pay for meningococcal conjugate vaccines for their teenage children.

Methods:

A conjoint analysis survey was administered to parents who had received counselling on the nature and risks of meningococcal disease in young people. In each country, half were randomly assigned to view a video with graphical depictions of the effects of meningococcaemia. Subjects were then shown a series of 18 sets of three vaccine descriptions. Each description listed the price of a hypothetical vaccine (range €15–304; 2001 values), the duration of protection, and the number of serogroups of the bacteria covered. The survey asked which vaccine they preferred and whether they would buy it. Conditional logit and generalised linear-random effects logit models assessed the effect of product attributes, personal background and video viewership on the probability of indicating a purchase.

Results:

92.6% of subjects would purchase at least one of the vaccines they encountered. Price elasticity ranged from -1.20 (France) to -2.48 (Germany). Exposure to graphical depictions of disease consequences negligibly increased the overall willingness to purchase vaccine in French participants, but lowered the overall willingness in German participants.

Conclusion:

In Germany and France, where there is still limited out-of-pocket health spending, the majority of sampled respondents stated that they would purchase meningococcal vaccines with their own money.
Literature
1.
go back to reference Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med 2001 May 3; 344 (18): 1378–88PubMedCrossRef Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med 2001 May 3; 344 (18): 1378–88PubMedCrossRef
2.
go back to reference Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J 2004 Dec; 23 (12 Suppl.): S274–9PubMed Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J 2004 Dec; 23 (12 Suppl.): S274–9PubMed
3.
go back to reference Trotter CL, Edmunds WJ. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ 2002 Apr 6; 324 (7341): 809PubMedCrossRef Trotter CL, Edmunds WJ. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ 2002 Apr 6; 324 (7341): 809PubMedCrossRef
4.
go back to reference Fergus S, Zimmerman MA. Adolescent resilience: a framework for understanding healthy development in the face of risk. Annu Rev Public Health 2004 Oct 26; 26: 399–419CrossRef Fergus S, Zimmerman MA. Adolescent resilience: a framework for understanding healthy development in the face of risk. Annu Rev Public Health 2004 Oct 26; 26: 399–419CrossRef
5.
go back to reference Welte R, Trotter CL, Edmunds WJ, et al. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine. Pharmacoeconomics 2005; 23 (9): 855–74PubMedCrossRef Welte R, Trotter CL, Edmunds WJ, et al. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine. Pharmacoeconomics 2005; 23 (9): 855–74PubMedCrossRef
6.
go back to reference Jackson LA, Schuchat A, Gorsky RD, et al. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Am J Public Health 1995 Jun; 85 (6): 843–5PubMedCrossRef Jackson LA, Schuchat A, Gorsky RD, et al. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Am J Public Health 1995 Jun; 85 (6): 843–5PubMedCrossRef
7.
go back to reference Viscusi WK. The value of risks to life and health. J Econ Lit 1993; 31: 1912–46 Viscusi WK. The value of risks to life and health. J Econ Lit 1993; 31: 1912–46
8.
go back to reference Shepard CW, Ortega-Sanchez IR, Scott RD, et al. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics 2005 May; 115 (5): 1220–32PubMedCrossRef Shepard CW, Ortega-Sanchez IR, Scott RD, et al. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics 2005 May; 115 (5): 1220–32PubMedCrossRef
9.
go back to reference Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2005 May 27; 54 (RR-7): 1–21PubMed Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2005 May 27; 54 (RR-7): 1–21PubMed
10.
go back to reference Bridges JF. Future challenges for the economic evaluation of healthcare: patient preferences, risk attitudes and beyond. Pharmacoeconomics 2005; 23 (4): 317–21PubMedCrossRef Bridges JF. Future challenges for the economic evaluation of healthcare: patient preferences, risk attitudes and beyond. Pharmacoeconomics 2005; 23 (4): 317–21PubMedCrossRef
11.
go back to reference Trotter CL, Edmunds WJ. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Med Decis Making 2006 Jan–Feb; 26 (1): 38–47PubMedCrossRef Trotter CL, Edmunds WJ. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Med Decis Making 2006 Jan–Feb; 26 (1): 38–47PubMedCrossRef
12.
go back to reference Prosser LA, Bridges CB, Uyeki TM, et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes 2005; 3 (1): 18PubMedCrossRef Prosser LA, Bridges CB, Uyeki TM, et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes 2005; 3 (1): 18PubMedCrossRef
13.
go back to reference Prosser LA, Ray GT, O’Brien M, et al. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics 2004 Feb; 113 (2): 283–90PubMedCrossRef Prosser LA, Ray GT, O’Brien M, et al. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics 2004 Feb; 113 (2): 283–90PubMedCrossRef
14.
go back to reference Pauly MV. Valuing health care benefits in money terms. In: Sloan F, editor. Valuing health care. Cambridge: Cambridge University Press, 1996 Pauly MV. Valuing health care benefits in money terms. In: Sloan F, editor. Valuing health care. Cambridge: Cambridge University Press, 1996
15.
go back to reference Vogt F, Schwappach DL, Bridges JF. Accounting for tastes: a German perspective on the inclusion of patient preferences in healthcare. Pharmacoeconomics 2006; 24 (5): 419–23PubMedCrossRef Vogt F, Schwappach DL, Bridges JF. Accounting for tastes: a German perspective on the inclusion of patient preferences in healthcare. Pharmacoeconomics 2006; 24 (5): 419–23PubMedCrossRef
16.
go back to reference Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2003; 2 (1): 55–64PubMed Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2003; 2 (1): 55–64PubMed
17.
go back to reference Ryan M, Bate A, Eastmond CJ, et al. Use of discrete choice experiments to elicit preferences. Qual Health Care 2001 Sep; 10 Suppl. 1: i55–60PubMedCrossRef Ryan M, Bate A, Eastmond CJ, et al. Use of discrete choice experiments to elicit preferences. Qual Health Care 2001 Sep; 10 Suppl. 1: i55–60PubMedCrossRef
18.
go back to reference Eppright DR, Hunt JB, Tanner JF, et al. Fear, coping, and information: a pilot study on motivating a healthy response. Health Mark Q 2002; 20 (1): 51–73PubMedCrossRef Eppright DR, Hunt JB, Tanner JF, et al. Fear, coping, and information: a pilot study on motivating a healthy response. Health Mark Q 2002; 20 (1): 51–73PubMedCrossRef
19.
go back to reference Janis I, Feshbach S. Effects of fear-arousing communications. J Abnorm Soc Psychol 1953; 48 (1): 78–92CrossRef Janis I, Feshbach S. Effects of fear-arousing communications. J Abnorm Soc Psychol 1953; 48 (1): 78–92CrossRef
20.
go back to reference ABC News. Campus killer. 20/20 [aired 1999 Sep 17]. New York: ABC, 1999 ABC News. Campus killer. 20/20 [aired 1999 Sep 17]. New York: ABC, 1999
21.
go back to reference Louviere JJ. Analyzing decision-making: metric conjoint analysis. London: Sage Publications, 1988 Louviere JJ. Analyzing decision-making: metric conjoint analysis. London: Sage Publications, 1988
22.
go back to reference Sawtooth Software Inc. The CBC system user’s manual. Evanston (IL): Sawtooth Technologies, 1999 Sawtooth Software Inc. The CBC system user’s manual. Evanston (IL): Sawtooth Technologies, 1999
23.
go back to reference Huber J, Zwerina K. The importance of utility balance in efficient choice designs. J Mark Res 1996; 33: 307–17CrossRef Huber J, Zwerina K. The importance of utility balance in efficient choice designs. J Mark Res 1996; 33: 307–17CrossRef
24.
go back to reference Chrzan K. An overview and comparison of design strategies for choice-based conjoint analysis. Sequim (WA): Sawtooth Software Inc., 2000 Chrzan K. An overview and comparison of design strategies for choice-based conjoint analysis. Sequim (WA): Sawtooth Software Inc., 2000
25.
go back to reference Miguel FS, Ryan M, Amaya-Amaya M. ‘Irrational’ stated preferences: a quantitative and qualitative investigation. Health Econ 2005 Mar; 14 (3): 307–22PubMedCrossRef Miguel FS, Ryan M, Amaya-Amaya M. ‘Irrational’ stated preferences: a quantitative and qualitative investigation. Health Econ 2005 Mar; 14 (3): 307–22PubMedCrossRef
26.
go back to reference White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980; 48 (4): 817–38CrossRef White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980; 48 (4): 817–38CrossRef
27.
go back to reference Rabe-Hesketh S, Skrondal A. Reliable estimation of generalized linear mixed models using adaptive quadrature. Stata J 2002; 2 (1): 1–21 Rabe-Hesketh S, Skrondal A. Reliable estimation of generalized linear mixed models using adaptive quadrature. Stata J 2002; 2 (1): 1–21
28.
go back to reference Hausman JA. Specification tests in econometrics. Econometrica 1978; 46 (6): 1251–71CrossRef Hausman JA. Specification tests in econometrics. Econometrica 1978; 46 (6): 1251–71CrossRef
29.
go back to reference National Conference of State Legislatures. Meningitis laws by state [online]. Available from URL: http://www.ncsl.org/programs/health/meningitisleg.htm [Accessed 2006 Dec 4] National Conference of State Legislatures. Meningitis laws by state [online]. Available from URL: http://​www.​ncsl.​org/​programs/​health/​meningitisleg.​htm [Accessed 2006 Dec 4]
30.
go back to reference Rajecki DW. Persuasive communication and attitudes: attitudes. Sunderland (MA): Sinauer Associates, 1990 Rajecki DW. Persuasive communication and attitudes: attitudes. Sunderland (MA): Sinauer Associates, 1990
Metadata
Title
Conjoint Analysis of French and German Parents’ Willingness to Pay for Meningococcal Vaccine
Authors
Dr David Bishai
Roger Brice
Isabelle Girod
Aneta Saleh
Jenifer Ehreth
Publication date
01-02-2007
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 2/2007
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200725020-00006

Other articles of this Issue 2/2007

PharmacoEconomics 2/2007 Go to the issue

Original Research Article

Acute/Subacute Herpes Zoster